In addition, Liu et al. (2022) found that CEP192 expression was closely associated with an immunosuppressive tumor microenvironment and low immune phenotype scores, making it a potential predictor of HCC immune checkpoint inhibitor response. Here, CEP192 is linked to hepatocellular carcinoma.